Medtech SA Sustainability Profile
Medtech SA, a prominent player in the medical technology sector, is headquartered in France and operates extensively across Europe. Founded in the early 2000s, the company has established itself as a leader in innovative healthcare solutions, focusing on advanced medical devices and diagnostic tools. Medtech SA is renowned for its cutting-edge products, which include state-of-the-art imaging systems and patient monitoring technologies, designed to enhance clinical outcomes and streamline healthcare processes. The company’s commitment to quality and innovation has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with leading healthcare institutions. With a focus on improving patient care and operational efficiency, Medtech SA continues to drive advancements in the medtech industry, making significant contributions to the future of healthcare.
DitchCarbon Score
How does Medtech SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtech SA's score of 51 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medtech SA, headquartered in France, currently does not report specific carbon emissions data for the most recent year, as no absolute emissions figures are available. The company is a current subsidiary of Zimmer Biomet Holdings, Inc., and thus may inherit emissions data and climate commitments from its parent organisation. As part of its climate strategy, Medtech SA aligns with the sustainability initiatives of Zimmer Biomet Holdings, Inc., which includes commitments to Science-Based Targets Initiative (SBTi) and CDP reporting. However, specific reduction targets or achievements for Medtech SA have not been disclosed. The absence of direct emissions data highlights the importance of corporate responsibility in the medtech industry, where companies are increasingly expected to demonstrate transparency and commitment to reducing their carbon footprint. Medtech SA's climate commitments are likely influenced by the broader goals set by Zimmer Biomet, reflecting a growing trend in the sector towards sustainability and environmental stewardship.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
How Carbon Intensive is Medtech SA's Industry?
How Carbon Intensive is Medtech SA's Location?
Medtech SA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medtech SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
